ALLOTCBB Top Rated Top Upgraded Most Active Gainers Losers

6.6 -0.25 (-3.65%)  02-20 15:12
Open: 6.589 Prev Close: 6.85
High: 6.6 Low: 6.589
Volume: 1,900 Market Cap: 310M
Year High: 7.25 Year Low: 4.67
Stock Technical Analysis
Targets Six months: 8.4680    One year: 9.8906
Supports Support1: 6.2776   Support2: 5.6765
Resistances Resistance1: 7.2500    Resistance2: 8.4680 
Pivot Point 6.7205 
Moving Averages MA(5): 6.8160      MA(20): 6.7709 

MA(100): 6.2171  1     MA(250): 5.6016 
MACD MACD(12,26): 0.009      Signal(12,26,9): 0.018 
Stochastic Oscillator %K(14,3): 59.568      %D(3): 64.712 
RSI RSI(14): 47.831 
52-Week High: 7.2500  Low: 4.6700  Change(%): 25
Average Volume(K) 3-Month: 441  10-Days: 439
Moving Averages analysis
Price and moving averages has closed below its Short term moving average. Short term moving average is above its mid-term; and above long term moving averages. From the relationship between price and moving averages; we can see that: this stock is NEUTRAL in short-term; and BULLISH in mid-long term.
Bollinger Bands Analysis
Bollinger Bands has closed above bottom band by 40.5%; Bollinger Bands are 29.4% wider than normal.The current width of the bands does not suggest anything about the future direction or movement of prices.


Stock Chart

Top 100 stocks

Stock News
CLINUVEL unveils new global positioning
Tue, 20 Feb 2018 03:45:00 GMT

Clinuvel: Laying The First Brick For A Fortress Of Commercial Success
Thu, 19 Jan 2017 17:07:37 GMT

Clinuvel: High Cash Returns - Catalysts For Growth Lined Up
Fri, 10 Nov 2017 22:07:30 GMT

CLINUVEL unveils new global positioning Australian Stock Exchange:CUV.AX
Tue, 20 Feb 2018 03:45:00 GMT

Clinuvel Pharmaceuticals to offer treatment for light-induced disorder
Wed, 01 Jul 2015 23:38:07 GMT

Nasdaq Welcomes Cielo SA to the Nasdaq International Designation
Mon, 22 Jan 2018 14:26:15 GMT

Piedmont Lithium Limited Joins Nasdaq International Designation
Wed, 11 Oct 2017 13:07:30 GMT

Clinuvel Pharmaceuticals provides update on Scenesse FDA filing
Mon, 18 Sep 2017 23:24:15 GMT

Clinuvel Pharmaceuticals says FY net profit for the period attributable $7.1 mln
Wed, 30 Aug 2017 07:25:37 GMT

Clinuvel Pharmaceuticals says it reached an agreement with German National Association Of Statutory Health Insurance Funds
Wed, 12 Apr 2017 01:26:47 GMT